SCHEMBL4478294

SCHEMBL4478294

Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)[nH]1.N#Cc1ccccc1-n1ccc(OCc2ccccc2)c(Br)c1=O

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4484282 0.88 MAPK14 (0.55) MAPK14
SCHEMBL4377615 0.79 MAPK14 (0.55) MAPK14
SCHEMBL4380696 0.76 MAPK14 (0.56) MAPK14
SCHEMBL4508164 0.72 MAPK14 (0.49) MAPK14
SCHEMBL4384403 0.72 MAPK14 (0.70) MAPK14
SCHEMBL6500546 0.71 MAPK14 (0.49) MAPK14
SCHEMBL4382794 0.70 MAPK14 (0.56) MAPK14
SCHEMBL4382919 0.70 MAPK14 (1.00) MAPK14
SCHEMBL4380067 0.68 MAPK14 (0.81) MAPK14
SCHEMBL13635334 0.66 MAPK14 (0.47) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed